Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSL425 (Panvax) in healthy adults for H1N1 influenza
NCT00938639Phase 2Completed
- Sponsor
- CSL Seqirus
- Start
- Jul 2009
- Primary completion
- Sep 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant influenza ha vaccine (h5n1) in influenza A H1N1 infection (H1N1), sponsored by CSL Seqirus. Started Jul 2009; status: completed.
02
Drugs
recombinant influenza ha vaccine (h5n1)
03
Conditions
influenza A H1N1 infection (H1N1)
Beyond the preview
Go deeper on NCT00938639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00938639.